For instance, DLL3 is more highly expressed in metastatic CRC tumors than in primary lesions, and its diagnostic role with prognostic value and therapeutic potential for anti-cancer therapy has been suggested [37]. This evidence concerns the gene DLL3 and colorectal carcinoma.